T1	Disorder 0 8	Seizures
N1 	Reference T1 UMLS:C0036572	Seizures
T2	Pharmacological_substance 181 193	medetomidine
N1000 	Reference T2 MeSH:D020926	medetomidine
T3	Disorder 297 304	seizure
N2 	Reference T3 UMLS:C0036572	seizure
T4	Pharmacological_substance 368 380	medetomidine
N1001 	Reference T4 MeSH:D020926	medetomidine
T5	Disorder 423 431	seizures
N3 	Reference T5 UMLS:C0036572	seizures
T6	Pharmacological_substance 476 488	medetomidine
N1002 	Reference T6 MeSH:D020926	medetomidine
T7	Disorder 576 584	seizures
N4 	Reference T7 UMLS:C0036572	seizures
T8	Pharmacological_substance 768 780	medetomidine
N1003 	Reference T8 MeSH:D020926	medetomidine
T9	Pharmacological_substance 785 795	lignocaine
N1004 	Reference T9 MeSH:D008012	lignocaine
T10	Disorder 842 850	seizures
N5 	Reference T10 UMLS:C0036572	seizures
T11	Pharmacological_substance 922 932	lignocaine
N1005 	Reference T11 MeSH:D008012	lignocaine
T12	Pharmacological_substance 939 951	medetomidine
N1006 	Reference T12 MeSH:D020926	medetomidine
T13	Subject 64 72	two dogs
T14	Pharmacological_substance 16 29	medetomindine
N1007 	Reference T14 MeSH:D020926	medetomindine
T15	Pharmacological_substance 198 208	lignocaine
N1008 	Reference T15 MeSH:D008012	lignocaine
T17	Subject 105 113	two dogs
T19	Combination 194 197	and
T20	Pharmacological_substance 386 397	atipamezole
N1009 	Reference T20 MeSH:C050701	atipamezole
T21	Subject 283 290	One dog
T25	Subject 403 412	other dog
T27	Subject 520 529	Both dogs
T29	Speculation_cue 799 808	suspected
T30	Combination 933 938	under
T32	Speculation_cue 828 837	potential
T16	Pharmacological_substance 507 518	atipamezole
N1010 	Reference T16 MeSH:C050701	atipamezole
